Oakbrook Investments’s Quest Diagnostics DGX Stock Holding History

Oakbrook Investments’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,750	Closed	-$400K	–	194
2019 Q4	$400K	Sell	3,750 -7,875	-68%	-$821K	0.08%	388
2019 Q3	$1.24M	Buy	11,625 +4,975	+75%	+$511K	0.08%	192
2019 Q2	$677K	Sell	6,650 -290	-4%	-$27.9K	0.04%	335
2019 Q1	$624K	Sell	6,940 -6,970	-50%	-$604K	0.04%	351
2018 Q4	$1.16M	Buy	+13,910	New	+$1.3M	0.08%	190
2018 Q1	–	Sell	-5,200	Closed	-$512K	–	582
2017 Q4	$512K	Buy	+5,200	New	+$493K	0.03%	344
2017 Q2	–	Sell	-11,400	Closed	-$1.12M	–	536
2017 Q1	$1.12M	Buy	11,400 +4,850	+74%	+$462K	0.07%	201
2016 Q4	$602K	Buy	+6,550	New	+$565K	0.04%	318

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Oakbrook Investments's DGX Position: Q1 2020 in Review

Oakbrook Investments sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 3,750 shares — an estimated $400K sold.

Oakbrook Investments first reported a position in DGX in Q4 2016 and held it in 8 quarters. The position peaked at $1.24M in Q3 2019. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

Oakbrook Investments reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
Oakbrook Investments sold 3,750 Quest Diagnostics shares in Q1 2020, an estimated $400K.
Oakbrook Investments first reported a position in Quest Diagnostics in Q4 2016 and held it in 8 quarters.
Oakbrook Investments's Quest Diagnostics position peaked at $1.24M in Q3 2019.
714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.